Company Filing History:
2 out of 15,502 
2 out of 917 
2 out of 832,880 Years Active: 1997-1998
Title: Hisashi Harada: Innovator in Tumorigenicity Diagnosis
Introduction
Hisashi Harada is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of cancer research, particularly in the diagnosis of tumorigenicity. His innovative work has led to the development of methods that can potentially transform cancer diagnostics and treatment.
Latest Patents
Hisashi Harada holds 2 patents. His latest patents focus on "Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity." This invention relates to a method for diagnosing tumorigenic mammalian cells and assessing the propensity of these cells to become tumorigenic. The invention also includes a cloned cDNA or genomic DNA aimed at reducing the likelihood of a cell becoming tumorigenic. Furthermore, it outlines methods for treating patients predisposed to cancer development and diagnosing tumorigenic tissues.
Career Highlights
Throughout his career, Harada has worked at esteemed institutions such as the University of California and the University of New Mexico. His research has been pivotal in advancing our understanding of tumorigenicity and developing diagnostic methods that could lead to better patient outcomes.
Collaborations
Some of his notable coworkers include Tadatsugu Taniguchi and Cheryl L Willman. Their collaborative efforts have contributed to the advancements in cancer research and diagnostics.
Conclusion
Hisashi Harada's work in the field of tumorigenicity diagnosis exemplifies the impact of innovative research on healthcare. His contributions continue to pave the way for advancements in cancer diagnostics and treatment methodologies.